where σ
2
is the variance of the total scores and σ
2
i
is the variance of the set of 0,1 scores
representing correct and incorrect answers on item i. The theoretical range of the coefficient
is 0 to 1. Suggested guidelines for interpretation are < 0.60 unacceptable, 0.60–0.65
undesirable, 0.65–0.70 minimally acceptable, 0.70–0.80 respectable, 0.80–0.90 very
good, and > 0.90 consider shortening the scale by reducing the number of items.
[Statistical Evaluation of Measurement Errors: Design and Analysis of Reliability Studies,
2004, G. Dunn, Arnold, London.]
Cross-correlation function: See multiple time series.
Cross-covariance function: See multiple time series.
Crossed treatments: Two or more treatments that are used in sequence (as in a
crossover design
)
or in combination (as in a
factorial design
).
Crossover design: A type of
longitudinal study
in which subjects receive different treatments on
different occasions. Random allocation is used to determine the order in which the treat-
ments are received. The simplest such design involves two groups of subjects, one of which
receives each of two treatments, A and B, in the order AB, while the other receives them in
the reverse order. This is known as a two-by-two crossover design. Since the treatment
comparison is ‘within-subject’ rather than ‘between-subject’, it is likely to require fewer
subjects to achieve a given
power
. The analysis of such designs is not necessarily straight-
forward because of the possibility of carryover effects, that is residual effects of the treat-
ment received on the first occasion that remain present into the second occasion. An attempt
to minimize this problem is often made by including a
wash-out period
between the two
treatment occasions. Some authorities have suggested that this type of design should only be
used if such carryover effects can be ruled out a priori. Crossover designs are only
applicable to chronic conditions for which short-term relief of symptoms is the goal rather
than a cure. See also three-period crossover designs. [SMR Chapter 15.]
Crossover rate: The proportion of patients in a
clinical trial
transferring from the treatment decided
by an initial random allocation to an alternative one.
Cross-sectional study: A study not involving the passing of time. All information is collected at
the same time and subjects are contacted only once. Many surveys are of this type. The
temporal sequence of cause and effect cannot be addressed in such a study, but it may be
suggestive of an association that should be investigated more fully by, for example, a
prospective study
. [SMR Chapter 5.]
Cross-spectral density: See multiple time series.
Cross-validation: The division of data into two approximately equal sized subsets, one of which is
used to estimate the parameters in some model of interest, and the second is used to assess
whether the model with these parameter values fits adequately. See also bootstrap and
jackknife. [MV2 Chapter 9.]
CRP: Abbreviation for Chinese restaurant process.
Crude annual death rate: The total deaths during a year divided by the total midyear population.
To avoid many decimal places, it is customary to multiply death rates by 100 000 and
express the results as deaths per 100 000 population. See also age-specific death rates and
cause specific death rates. In 2005 the and annual death rate per 100 000 population ranged
from 242 in Kuwait to 2936 in Botswana.
Crude risk: Synonym for incidence rate.
116